Sanofi-Aventis and Bristol-Myers Squibb have cut a deal with a generic company that could keep a copycat version of their multibillion drug Plavix off the market until 2011. Sanofi-Aventis and Bristol ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any ...

A former senior vice-president at Bristol-Myers Squibb has been charged by the US Department of Justice with lying to federal authorities over a deal struck with rival generics maker Apotex. According ...

The NHS states: "Like all medicines, clopidogrel can cause side effects, although not everyone gets them. These common side effects of clopidogrel happen in more than 1 in 100 people." You're vomiting ...